How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Close this folder1 INTRODUCTION
View the documentObjectives
View the documentThe need for formularies
View the documentWhat is a formulary?
View the documentThe essential medicines concept
View the documentThe WHO model list of essential medicines and the WHO model formulary
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

The WHO model list of essential medicines and the WHO model formulary

The WHO model list of essential medicines (WMLEM) (3) identifies over 300 medicinal agents and devices for the prevention or treatment of priority diseases. In 2002, WHO released the first edition of the WHO model formulary. The second revised edition based on the thirteenth Model list of essential medicines was published in 2004. This formulary contains detailed information about the indications, dosage, adverse effects, contra-indications and warnings for medicines included in the WMLEM, together with summaries of recommendations on their appropriate use.

The WMF is intended to be a starting point for national governments and institutions to develop their own formularies, as well as an information source for individual prescribers. A NF or institutional formulary will be different from the WMF because of the addition of locally useful information on treatment of prevalent diseases, prices, distribution rules and other locally relevant details (see Box 1.1). Country-specific information will be discussed in Chapters 2, 3 and 6.

The WMF is freely available on the Internet.3 It is also available on CD-ROM in different file formats that can be used for electronic editing of NFs. The WMF will be updated every two years and will continue to be available in electronic formats to support the review and update of NFs.

3 The WMF is available on the Internet at: http://mednet3.who.int/eml/modelFormulary.asp


Box 1.1. Difference between content of the WHO model formulary and a national formulary

Content

WHO model formulary

National formulary

General advice to prescribers

Individual drug information

Therapeutic information, recommendations

Medicine prices

-

Brand names

-

Availability at health facilities

-

National policies on prescribing/dispensing

-

Reference to, or brief summary of, local guidelines

-

Specific information on drug interactions, prescribing in pregnancy, breastfeeding, hepatic and renal impairment

Forms for reporting of adverse drug reactions and product quality problems

-

Nomograms, dose calculators or other tools

-

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014